This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $91,800
Comparative Efficacy and Safety of GLP-1 Receptor Agonists and Co-Agonists for Weight Loss Among Adults with Overweight or Obesity without Diabetes: A Systematic Review and Network Meta-Analysis
CIHR · 2026 · Co-investigator
- $497,250
Use of ultra-long-acting insulin versus long-acting insulin in the management of type 2 diabetes and the risk of adverse renal outcomes among people with diabetic kidney disease
CIHR · 2026 · Nominated PI
- $179,776
The association between denosumab and the risk of atypical femoral fractures in osteoporosis management
CIHR · 2023 · Co-investigator
Comparative Efficacy and Safety of GLP-1 Receptor Agonists and Co-Agonists for Weight Loss Among Adults with Overweight or Obesity without Diabetes: A Systematic Review and Network Meta-Analysis
Principal investigators: Eisenberg, Mark J
Keywords: Glp-1 Receptor Agonists; Incretin Co-Agonists; Network Meta-Analysis; Obesity Pharmacotherapy; Systematic Review; Weight Management
Use of ultra-long-acting insulin versus long-acting insulin in the management of type 2 diabetes and the risk of adverse renal outcomes among people with diabetic kidney disease
Principal investigators: Filion, Kristian B
Keywords: Chronic Kidney Desease; Cohort Study; Comparative Effectiveness; Diabetic Kidney Disease; Dialysis; Insulin; Pharmacoepidemiology; Real-World Data; Renal Failure; Type 2 Diabetes
The association between denosumab and the risk of atypical femoral fractures in osteoporosis management
Principal investigators: Yu, Oriana Hoi Yun
Keywords: Atypical Femoral Fractures; Denosumab; Osteoporosis; Population Cohort Study
Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum
Principal investigators: Bourbeau, Jean; Anderson, David R; Batist, Gerald; Bell, Emily C; Benoit, Britney L; Collister, David; Dasgupta, Kaberi; Fahim, Christine; Fergusson, Dean A; Filion, Kristian B; Gahagan, Jacqueline C; Goos, Lisa; Khan, Nadia A; King, Malcolm; Li, Linda C; Mitra, Souvik; Morin, Suzanne N; Pilote, Louise; Reiman, Tony; Richer, Lawrence P; Saleh, Ramy R; Sapp, John L; Tomblin Murphy, Gail G; Yeh, Ann E.
Keywords: Clinical Trial Design; Clinical Trial Professional; Clinical Trial Training; Equity, Diversity, And Inclusion Best Practices; Gender-Based Clinical Trial And Analysis; Mentoring Platform; Patient Partner; Professional Education; Research Involving Indigenous People; Training Platform
Comparative Effectiveness of Long-acting Insulins and Neutral Protamine Hagedorn (NPH) Insulin for the Prevention of Micro- and Macrovascular Complications Among Patients with Type 1 Diabetes
Principal investigators: Filion, Kristian B
Keywords: Cardiovascular Events; Cohort Study; Comparative Effectiveness; Insulin; Nephropathy; Neuropathy; Pharmacoepidemiology; Population Health; Retinopathy; Type 1 Diabetes
Developing Statistical Tools and Visualization Methods for Understanding Heterogeneity in Distributed Networks: Applications to COVID-19 and Diabetes
Principal investigators: Platt, Robert W
Keywords: Covid-19; Distributed Networks; Effect Measure Modification; Epidemiology; Heterogeneity; Methods Development; Observational Studies; Real-World Data
AI & Personalized Therapeutics
Principal investigators: Tamblyn, Robyn M; Filion, Kristian B; McDonald, Emily G; Singer, Wendy
Keywords: Artificial Intelligence; Big Data; Machine Learning; Patient-Reported Outcomes; Personalized Medicine; Pharmacare; Pragmatic Trials; Predictive Analytics; Reinforcement Learning
Canadian Consortium of Clinical Trial Training (CANTRAIN) platform: enhancing career preparedness in RCT research targeting different audiences across the continuum
Principal investigators: Bourbeau, Jean; Anderson, David R; Batist, Gerald; Bell, Emily C; Benoit, Britney L; Collister, David; Dasgupta, Kaberi; Fahim, Christine; Fergusson, Dean A; Filion, Kristian B; Gahagan, Jacqueline C; Goos, Lisa; Khan, Nadia A; King, Malcolm; Li, Linda C; Mitra, Souvik; Morin, Suzanne N; Pilote, Louise; Reiman, Tony; Richer, Lawrence P; Saleh, Ramy R; Sapp, John L; Tomblin Murphy, Gail G; Yeh, Ann E.
Keywords: Clinical Trial Design; Clinical Trial Professional; Clinical Trial Training; Equity, Diversity, And Inclusion Best Practices; Gender-Based Clinical Trial And Analysis; Mentoring Platform; Patient Partner; Professional Education; Research Involving Indigenous People; Training Platform
Direct Oral Anticoagulants, Warfarin, and the Risk of Adverse Renal Outcomes Among People with Non-Valvular Atrial Fibrillation
Principal investigators: salmasi, shahrzad
Keywords: Acute Kidney Injury; Atrial Fibrillation; Drug Safety And Effectiveness; Oral Anticoagulants; Prevalent New User Design
The Safety of Antipsychotic Drugs Among Children and Youth With Attention Deficit and Hyperactivity Disorder
Principal investigators: Filion, Kristian B
Keywords: Attention Deficit Hyperactivity Disorder; Cardiac Safety; Children; Cohort Study; Comparative Safety; Diabetes; Drug Safety; Obesity; Pharmacoepidemiology; Population Health
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.